
CLOV
USDClover Health Investments Corp. Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$3.330
Haut
$3.400
Bas
$3.254
Volume
0.44M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.7B
Industrie
Healthcare Plans
Pays
United States
Statistiques de Trading
Volume Moyen
5.63M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 3 mai 2025CLOV: Clover Health Investments Corp. Class A Common Stock - Analyzing Recent Moves & What Might Come Next
Stock Symbol: CLOV Generate Date: 2025-05-03 20:26:19
Alright, let's break down what's been going on with Clover Health stock (CLOV) based on the latest information. We'll look at the recent news, check out what the price has been doing, and see what the AI crystal ball is hinting at.
Recent News Buzz - What's the Vibe?
Looking at the news headlines from the past couple of weeks, things seem to lean pretty positive for Clover Health.
First off, there's news about their subsidiary, Counterpart Health, and how using their tech with primary care doctors is linked to better results for patients dealing with congestive heart failure. That's a good sign, suggesting their technology platform, the Clover Assistant, is actually making a difference in patient care.
Then, there's a broader piece talking about how AI in healthcare could unlock billions in market value. This is relevant because Clover Health specifically uses AI through its Clover Assistant platform to help doctors. So, if the AI trend in healthcare is big, Clover is positioned right in the middle of it.
We also saw news about changes to the company's Board of Directors and plans to participate in upcoming investor conferences. Board changes are often just standard corporate stuff, not necessarily good or bad on their own. But going to investor conferences? That usually means the company is actively talking to potential investors, which is generally seen as a positive step.
So, putting it together, the recent news flow feels constructive. It highlights the potential benefits of their core technology and shows the company is engaging with the financial community.
Price Check - What's the Stock Been Doing?
Now, let's look at the stock price itself over the last couple of months. If you glance at the historical data, you'll see that after trading in the $4 range back in February, the price started a noticeable slide through March. It hit lows around the mid-$3 mark.
In April, the price seemed to find a bit of a floor, mostly bouncing around between $3.40 and $3.70, though there was one sharp dip below $3 briefly. More recently, in the last few days of April and early May, the stock has been trading pretty tightly, hovering right around the $3.30 to $3.40 level. The previous day's close was $3.32.
What about the AI's prediction for the very near future? The AI model suggests the price will stay flat today (0.00% change), but then tick up slightly over the next two days, predicting a 1.06% rise tomorrow and a 1.78% rise the day after. This suggests the AI sees a small upward move coming from the current price point.
Outlook & Strategy Ideas - Putting It All Together
So, what does this mix of news, price action, and AI prediction suggest?
The positive news about their tech and the broader AI trend in healthcare provides a potentially favorable backdrop. The price has been weak overall but seems to have settled into a recent range, and the AI is forecasting a modest bounce from here.
Based on this, the current situation might lean towards a 'hold' or perhaps a cautious 'accumulate' stance for those interested in the stock. The price is near the lower end of its recent trading range and close to a potential support level mentioned in the recommendation data ($3.35).
If you were considering getting involved, a potential entry area could be around the current price level, say between $3.30 and $3.40. This aligns with where the stock has been trading recently and where the AI predicts a slight upward move starting.
Thinking about managing risk, the recommendation data suggests a potential stop-loss level around $3.00. This is below the recent trading range and offers some room before cutting losses if the price were to fall further. For taking profits, the recommendation points to $3.40, which is right at the top of the recent tight trading range and aligns somewhat with the AI's short-term upward forecast. It could be a potential near-term target to watch.
Company Context
Just remember, Clover Health is primarily focused on Medicare Advantage plans and uses its technology platform, Clover Assistant, as a key part of its strategy. So, news related to healthcare tech, AI in medicine, and government programs like Medicare are particularly important to watch for this company.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Actualités Connexes
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") and
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity
Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down...
Clover Health Announces Changes to Board of Directors
WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that after four years of distinguished service, Lee A.
Clover Health to Participate in Upcoming Investor Conferences
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences:
Prédiction IABeta
Recommandation IA
Mis à jour le: 4 mai 2025, 07:06
61.9% Confiance
Risque et Trading
Point d'Entrée
$3.34
Prise de Bénéfices
$3.40
Stop Loss
$3.00
Facteurs Clés
Actions Connexes

CBH
Virtus Convertible & Income 2024 Target Term Fund Common Shares of Beneficial Interest

OCCI
OFS Credit Company Inc.

AQMS
Aqua Metals Inc.

MIST
Milestone Pharmaceuticals Inc. Common Shares

DBX
Dropbox Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.